About Innovative Medicine
Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.
Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.
Learn more at https://www.jnj.com/innovative-medicine
Johnson & Johnson Innovative Medicine (JJIM) is currently recruiting for an Associate Director, Global Market Access Operations & Excellence, within the Global Commercial Strategy Organization (GCSO), to be located in Raritan, NJ, United States or Beerse, Belgium.
About the Role
The Associate Director, Global Market Access Operations & Excellence will drive operational excellence across Global Market Access, with a primary focus on EU HTA Regulation readiness and execution. This high-impact role will help operationalize EU HTA across a global portfolio and support timely, high-quality execution of Joint Clinical Assessments and Joint Scientific Consultations.
The role sits within the Global HTA & Decision Science team in the Global Commercial Strategy Organization’s Market Access Center of Excellence and partners closely with Therapy Area and Regional Market Access, R&D, Regulatory Affairs, and other cross-functional teams worldwide, with a strong EMEA interface.
The HTA & Decision Science team helps ensure that development programs across the J&J Innovative Medicine portfolio address the needs of HTA agencies and payers globally. The team provides expertise on HTA and payer evidence requirements, champions access-led development, and supports organizational learning through consistent processes and best practices.
Key Responsibilities
EU HTA Regulation-related activities, including Joint Clinical Assessments (JCAs) and Joint Scientific Consultations (JSCs):
- Refine, adapt, and implement the internal end-to-end JCA process, including governance, submission readiness, and compliant document management. Coordinate and align with Regulatory Affairs on EMA submission and post-submission process steps.
- Lead operational execution and cross-functional coordination of JCA internal PICO scoping, dossier preparation, submission, and post-submission activities, including follow-up interactions with (co-) assessors for relevant assets across Therapy Areas. Ensure linkage to related activities such as scientific advice, and partner closely with R&D.
- Drive continuous improvement in the efficiency, quality, and consistency of dossier preparation, quality checks and workflow automation, including appropriate use of artificial intelligence and other digital solutions.
- Support resource planning for JCA-related activities across assets and functions, including budget, FTE capacity, and vendor planning.
- Ensure proactive planning for internal pipeline assets in scope for upcoming EU JCAs.
- Review and synthesize JCA reports to distill key insights and learnings for future programs and understand potential implications for HTA markets globally.
- Support external stakeholder engagement, including interactions with trade associations.
- Deliver training for relevant global stakeholders to enhance understanding of EU JCA processes, roles, responsibilities, and operational requirements.
- Manage submission and post-submission activities for JSCs, including cross-functional coordination and compliant document management.
Team Operations:
- Implement and maintain planning, milestone tracking, and knowledge management tools to support transparency, coordination, and compliant ways of working across the HTA & Decision Science team and broader Global Market Access organization.
Qualifications and Experience
- University degree in life sciences, pharmacy, health economics, public health, or a related field required; advanced degree such as MSc, MPH, PhD, PharmD, or equivalent preferred.
- At least 6 years of experience in Market Access, HTA, Regulatory Affairs, or related fields within a pharmaceutical organization, external agency, or consulting environment:
- Experience in Market Access and HTA, with a solid understanding of the EU HTA Regulation. Knowledge of national HTA, pricing, and reimbursement processes in key international markets, especially Europe, is preferred; and/or
- Solid understanding of regulatory authority processes, particularly those of the European Medicines Agency.
- Solid understanding of drug development and cross-functional evidence generation.
- Cross-therapy-area experience is preferred; oncology experience is an advantage.
Capabilities and Leadership Attributes
- Strong process and project management skills, with the ability to plan, prioritize, and deliver high-quality work compliantly in a matrixed environment with competing priorities and strict timelines. Experience with project management tools and resource planning is preferred.
- Demonstrated ability to quickly review and internalize external agency structures, evidence requirements, and submission processes, and to compare, interpret, and synthesize requirements across multiple agencies.
- Strong attention to detail, with ability to maintain quality and compliance under tight timelines.
- Global mindset with proven ability to collaborate across diverse, cross-functional teams.
- Strong verbal and written communication skills, with the ability to translate complex topics into clear, actionable messages.
- Intellectual curiosity and creativity to challenge existing approaches, identify improvements and alternatives, and develop practical, innovative solutions.
- Demonstrated commitment to continuous learning with ability to adapt to and create structure in ambiguous and evolving external environments
Locations:
- Raritan, NJ, United States, or Beerse, Belgium. Hybrid work model with three days per week in the office and two days from home. Domestic and International travel required, up to 20%.